Connection

Paola Rogliani to Interleukin-5

Back to Details
This is a "connection" page, showing publications Paola Rogliani has written about Interleukin-5.
Paola Rogliani
Connection Strength
0.219
Interleukin-5
  1. Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab. Expert Opin Drug Saf. 2018 Apr; 17(4):429-435.
    View in: PubMed
    Score: 0.176
  2. Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma. Expert Opin Drug Metab Toxicol. 2018 Feb; 14(2):239-245.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.